Filler

Saypha® Volume

For correcting moderate to severe nasolabial folds and medical reconstructive treatment, for instance, of facial lipoatrophy, debilitating scars, or morphological asymmetry

imageedit_1_8340731931

Saypha® Volume

/box

1 box of 1 mL syringe
Needle 2 x 27G .” thin wall Terumo™ needles (CE 0197)

Injection area : Deep dermis or subcutis

Highlights

Indication

For correcting moderate to severe nasolabial folds and medical reconstructive treatment, for instance, of facial lipoatrophy, debilitating scars, or morphological asymmetry

Est. duration in the skin

At least 9 months 

Arruda LHF, Costa A, Pereira ESP, de Oliveira Pereira M, Assumpcao EC (2013) Evaluation of Clinical Safety and Effectiveness of Hyaluronic Acid-based Temporary Dermal Filler Used in Nasolabial Folds. J Clin Exp Dermatol Res 4: 196. doi:10.4172/2155-9554.1000196,2 Kopera, D., Ivezic-Schoenfeld, Z., Federspiel, I. G., Grablowitz, D., Gehl, B., & Prinz, M. (2018). Treatment of facial lipoatrophy, morphological asymmetry, or debilitating scars with the hyaluronic acid dermal filler Princess. FILLER. Clinical, cosmetic and investigational dermatology, 11, 621–628. doi:10.2147/CCID.S181964, saypha. FILLER was previously known as Princess. FILLER

main ingredients

Concentration HA

2.3 % (23 mg/mL)
High molecular weight hyaluronic acid of non-animal origin

Crosslinking agent

BDDE (concentration ≤ 2 ppm)

Additional ingredients

Phosphate buffer, NaCl, 0.3% lidocaine hydrochloride

Indications

The device is indicated to correct moderate to severe nasolabial folds

Durations

Anticipated at least 9 months

I would like to book a free demo
Add to enquiry
Item added.View Enquiry
Need Help? Chat with us